Shares of Metlife Inc (NYSE:MET) have received an average rating of “Hold” from the twenty-two research firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have given a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $57.75.

MET has been the topic of several analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $60.00 price target (up previously from $56.00) on shares of Metlife in a report on Friday, November 3rd. Zacks Investment Research downgraded shares of Metlife from a “buy” rating to a “hold” rating in a research note on Monday, December 18th. Morgan Stanley raised their price objective on shares of Metlife from $54.00 to $55.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 5th. Sandler O’Neill downgraded shares of Metlife from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Finally, Deutsche Bank started coverage on shares of Metlife in a research note on Tuesday, January 2nd. They issued a “hold” rating and a $55.00 price objective on the stock.

Metlife (NYSE:MET) opened at $52.36 on Wednesday. Metlife has a twelve month low of $44.26 and a twelve month high of $55.91. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $55,100.00, a P/E ratio of 113.83, a price-to-earnings-growth ratio of 1.20 and a beta of 1.49.

Metlife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, beating the consensus estimate of $0.90 by $0.19. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The company had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. During the same quarter last year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. equities research analysts forecast that Metlife will post 4.4 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.06%. Metlife’s dividend payout ratio is currently 347.83%.

In other Metlife news, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the sale, the insider now owns 49,660 shares in the company, valued at $2,711,436. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christopher G. Townsend sold 55,712 shares of Metlife stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the sale, the insider now owns 25,181 shares in the company, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. QUANTRES ASSET MANAGEMENT Ltd bought a new position in shares of Metlife during the fourth quarter valued at $1,279,000. Aurora Investment Counsel bought a new position in shares of Metlife during the fourth quarter valued at $2,379,000. Parametric Portfolio Associates LLC lifted its holdings in shares of Metlife by 5.7% during the third quarter. Parametric Portfolio Associates LLC now owns 2,762,193 shares of the financial services provider’s stock valued at $143,496,000 after acquiring an additional 147,992 shares during the period. Steward Partners Investment Advisory LLC bought a new position in shares of Metlife during the third quarter valued at $867,000. Finally, First Fiduciary Investment Counsel Inc. lifted its holdings in shares of Metlife by 1.3% during the third quarter. First Fiduciary Investment Counsel Inc. now owns 306,685 shares of the financial services provider’s stock valued at $15,932,000 after acquiring an additional 3,975 shares during the period. Hedge funds and other institutional investors own 76.24% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/10/metlife-inc-met-receives-average-recommendation-of-hold-from-analysts.html.

About Metlife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.